Al-Attar, Nawwar
Johnston, Stephen
Jamous, Nadine
Mistry, Sameer
Ghosh, Ena
Gangoli, Gaurav
Danker, Walter
Etter, Katherine
Ammann, Eric
Funding for this research was provided by:
Johnson and Johnson
Article History
Received: 14 December 2018
Accepted: 4 March 2019
First Online: 2 April 2019
Ethics approval and consent to participate
: The HES-APC and CPRD study data were de-identified and obtained under license from the UK Medicines and Healthcare Products Regulatory Agency (MHRA). Throughout the duration of the study, the data were stored on encrypted, password-protected servers to protect patient confidentiality. The study protocol (number 17_091R) was reviewed and approved by the Independent Scientific Advisory Committee for MHRA Database Research.
: Not applicable.
: E. Ammann, S. Johnston, N. Jamous, S. Mistry, G. Gangoli, W. Danker, and K. Etter are employed by Johnson & Johnson. E. Ghosh is employed by Mu Sigma. Mu Sigma was paid by Johnson & Johnson to conduct the study. N. Al-Attar reports no disclosures.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.